Human Microbiome Therapeutics Market Projected to Surge at 29.8% CAGR, Driven by Clinical Advances and AI-Personalization

The Global Human Microbiome Therapeutics Market is expected to reach a CAGR of 29.8% during the forecast period (2024-2031).

According to DataM Intelligence has published a new research report on "Human Microbiome Therapeutics Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.

Human microbiome therapeutics are medical and biological treatments designed to modulate the body's microbiome the community of microorganisms living in the gut, skin, oral cavity, and other organs to prevent, manage, or treat disease. These therapies include live biotherapeutic products (LBPs), microbiota-based drugs, engineered probiotics, prebiotics, postbiotics, and fecal microbiota derived therapies, with applications across gastrointestinal disorders, metabolic diseases, immunology, oncology, and neurology.

📌 Download Free Sample PDF:- https://www.datamintelligence.com/download-sample/human-microbiome-therapeutics?rk

➣ Recent Developments:

United States: Recent Industry Developments

✅ In July 2025, U.S. biotech companies advanced live biotherapeutic products (LBPs) into late-stage clinical trials for recurrent Clostridioides difficile infection and inflammatory bowel disease.
✅ In June 2025, FDA engagement increased around standardized microbiome drug development and manufacturing frameworks.
✅ In May 2025, investments grew in synthetic and engineered microbiome therapies targeting metabolic and immune-related disorders.

Europe: Recent Industry Developments

✅ In July 2025, European research consortia expanded microbiome-based therapies for gastrointestinal and autoimmune diseases.
✅ In June 2025, regulatory bodies supported quality and safety guidelines for live biotherapeutic medicinal products.
✅ In May 2025, collaborations focused on precision microbiome therapeutics using AI-driven microbiome profiling.

Asia-Pacific: Recent Industry Developments

✅ In July 2025, China and Japan increased clinical research in microbiome therapeutics for oncology and metabolic health.
✅ In June 2025, India expanded development of cost-effective microbiome-based formulations for gastrointestinal care.
✅ In May 2025, South Korea advanced next-generation microbiome therapeutics integrating genomics and personalized medicine.

📌 Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/human-microbiome-therapeutics?rk

➣ Top Industry Players:

BaseClear BV, Clinical Microbiomics AS, Locus Biosciences, Microbiome Insights Inc., Microbiome Therapeutics LLC, MR DNA, Second Genome, uBiome, Molzym GmbH, and Zymo Research Corp.

➣ Market Segments:

By Technology: Shotgun, Targeted Gene, RNA, Whole Genome, and others.

By Technique: Synthesis By Ligation, Pyro, Sanger, and others.

By Application: Therapeutics, Genetic Screening, Drug Discovery, Biomarker Discovery, Personalized Medicines, and others.

By End User: Research Institutes, Pharmaceutical, and Biotechnology Companies and others.

📌 Buy Now & Get 30% OFF - (Grab 50% OFF on 2+ reports) @: https://www.datamintelligence.com/buy-now-page?report=human-microbiome-therapeutics?rk

Regional Break out:

☞ North America - US, Canada, Mexico

☞ Europe- Germany, Russia, UK, France, Italy, Rest of Europe

☞ Asia Pacific- China, India, Japan, Australia, Rest of Asia Pacific

☞ South America- Brazil, Argentina, Colombia, Rest of South America

☞ Middle East and Africa- Saudi Arabia, UAE, Oman, Bahrain, Qatar, Kuwait, Israel

📌 Have any Enquiry of This Report @ https://www.datamintelligence.com/enquiry/human-microbiome-therapeutics-market?rk

☛ Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

☛ Get 2-Day Free Trial + 50% OFF DataM Subscription@ https://www.datamintelligence.com/reports-subscription?rk

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.